Lars Østergaard Kristensen

669 total citations
21 papers, 544 citations indexed

About

Lars Østergaard Kristensen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Lars Østergaard Kristensen has authored 21 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Lars Østergaard Kristensen's work include Growth Hormone and Insulin-like Growth Factors (10 papers), Pituitary Gland Disorders and Treatments (8 papers) and Metabolism, Diabetes, and Cancer (5 papers). Lars Østergaard Kristensen is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (10 papers), Pituitary Gland Disorders and Treatments (8 papers) and Metabolism, Diabetes, and Cancer (5 papers). Lars Østergaard Kristensen collaborates with scholars based in Denmark and Indonesia. Lars Østergaard Kristensen's co-authors include Mikkel Andreassen, Jens Faber, Caroline Kistorp, Ilan Raymond, Per Hildebrandt, Henrik Vestergaard, Ulla Feldt‐Rasmussen, Peter Laurberg, Jens Sandahl Christiansen and Torben Laursen and has published in prestigious journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, Journal of Affective Disorders and Clinical Endocrinology.

In The Last Decade

Lars Østergaard Kristensen

21 papers receiving 535 citations

Peers

Lars Østergaard Kristensen
J. Rodríguez‐Arnao United Kingdom
Michelle A. Mulcahey United States
S Molvalílar Türkiye
Asad Rahim United Kingdom
B. Quadbeck Germany
Michele Autelli Italy
Juraj Payer Slovakia
Yasuo Tokita Japan
E Sencer Türkiye
Maciej Hilczer Poland
J. Rodríguez‐Arnao United Kingdom
Lars Østergaard Kristensen
Citations per year, relative to Lars Østergaard Kristensen Lars Østergaard Kristensen (= 1×) peers J. Rodríguez‐Arnao

Countries citing papers authored by Lars Østergaard Kristensen

Since Specialization
Citations

This map shows the geographic impact of Lars Østergaard Kristensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Østergaard Kristensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Østergaard Kristensen more than expected).

Fields of papers citing papers by Lars Østergaard Kristensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Østergaard Kristensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Østergaard Kristensen. The network helps show where Lars Østergaard Kristensen may publish in the future.

Co-authorship network of co-authors of Lars Østergaard Kristensen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Østergaard Kristensen. A scholar is included among the top collaborators of Lars Østergaard Kristensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Østergaard Kristensen. Lars Østergaard Kristensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nygaard, Birte, et al.. (2015). Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency. European Thyroid Journal. 4(4). 222–225. 17 indexed citations
2.
Krogh, Jesper, Jens Peter Gøtze, Martin Balslev Jørgensen, et al.. (2013). Copeptin during rest and exercise in major depression. Journal of Affective Disorders. 151(1). 284–290. 24 indexed citations
3.
Madsen, Michael, Sanne Fisker, Ulla Feldt‐Rasmussen, et al.. (2013). Circulating levels of pegvisomant and endogenous growth hormone during prolonged pegvisomant therapy in patients with acromegaly. Clinical Endocrinology. 80(1). 92–100. 11 indexed citations
4.
Andreassen, Mikkel, Ilan Raymond, Per Hildebrandt, et al.. (2010). Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population. Inflammation Research. 59(7). 503–510. 9 indexed citations
5.
Andreassen, Mikkel, Jens Faber, Andreas Kjær, Claus Leth Petersen, & Lars Østergaard Kristensen. (2010). Cardiac effects of 3 months treatment of acromegaly evaluated by magnetic resonance imaging and B-type natriuretic peptides. Pituitary. 13(4). 329–336. 22 indexed citations
6.
Andreassen, Mikkel, Jens Faber, Andreas Kjær, Claus Leth Petersen, & Lars Østergaard Kristensen. (2010). Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study. Pituitary. 14(1). 1–10. 24 indexed citations
7.
Andreassen, Mikkel, Kaspar René Nielsen, Ilan Raymond, Lars Østergaard Kristensen, & Jens Faber. (2009). Characteristics and reference ranges of Insulin-Like Growth Factor-I measured with a commercially available immunoassay in 724 healthy adult Caucasians. Scandinavian Journal of Clinical and Laboratory Investigation. 69(8). 880–885. 11 indexed citations
8.
Andreassen, Mikkel, Caroline Kistorp, Ilan Raymond, et al.. (2009). Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure. Growth Hormone & IGF Research. 19(6). 486–490. 24 indexed citations
9.
Andreassen, Mikkel, Kaspar René Nielsen, Ilan Raymond, Lars Østergaard Kristensen, & Jens Faber. (2009). Characteristics and reference ranges of Insulin-Like Growth Factor-I measured with a commercially available immunoassay in 724 healthy adult Caucasians. Scandinavian Journal of Clinical and Laboratory Investigation. 1–6. 1 indexed citations
10.
Stochholm, Kirstine, Torben Laursen, Anders Green, et al.. (2008). Morbidity and GH deficiency: a nationwide study.. European Journal of Endocrinology. 158(4). 447–457. 33 indexed citations
11.
Andreassen, Mikkel, Ilan Raymond, Caroline Kistorp, et al.. (2008). IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. European Journal of Endocrinology. 160(1). 25–31. 103 indexed citations
12.
Boesby, Lene, Niels Juel Christensen, & Lars Østergaard Kristensen. (2008). [Somatostatin analogues in the treatment of bleeding GI-angiodysplasias].. PubMed. 170(11). 958–958. 5 indexed citations
13.
Andreassen, Mikkel, Jens Faber, Henrik Vestergaard, Caroline Kistorp, & Lars Østergaard Kristensen. (2007). N‐terminal pro‐B‐type natriuretic peptide in patients with growth hormone disturbances. Clinical Endocrinology. 66(5). 619–625. 13 indexed citations
14.
Stochholm, Kirstine, Claus Højbjerg Gravholt, Torben Laursen, et al.. (2007). Mortality and GH deficiency: a nationwide study. European Journal of Endocrinology. 157(1). 9–18. 105 indexed citations
15.
Andreassen, Mikkel, Henrik Vestergaard, & Lars Østergaard Kristensen. (2007). Concentrations of the acute phase reactants high‐sensitive C‐reactive protein and YKL‐40 and of interleukin‐6 before and after treatment in patients with acromegaly and growth hormone deficiency. Clinical Endocrinology. 67(6). 909–916. 22 indexed citations
16.
Andreassen, Mikkel & Lars Østergaard Kristensen. (2005). Rosiglitazone for prevention or adjuvant treatment of Nelson’s syndrome after bilateral adrenalectomy. European Journal of Endocrinology. 153(4). 503–505. 16 indexed citations
17.
Klose, Marianne, Karsten Juhl Jørgensen, & Lars Østergaard Kristensen. (2004). Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas. Clinical Endocrinology. 61(3). 394–399. 18 indexed citations
18.
19.
Kristensen, Lars Østergaard, et al.. (1986). Effects of perturbation of the Na + electrochemical gradient on influx and efflux of alanine in isolated rat hepatocytes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 855(1). 49–57. 16 indexed citations
20.
Birgens, Henrik, Hans Karle, Niels Ebbe Hansen, & Lars Østergaard Kristensen. (1984). Lactoferrin receptors in normal and leukaemic human blood cells. Scandinavian Journal of Haematology. 33(3). 275–280. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Rodríguez‐Arnao Breakdown of academic impact, for papers by Michelle A. Mulcahey Breakdown of academic impact, for papers by S Molvalílar Breakdown of academic impact, for papers by Asad Rahim Breakdown of academic impact, for papers by B. Quadbeck Breakdown of academic impact, for papers by Michele Autelli Breakdown of academic impact, for papers by Juraj Payer Breakdown of academic impact, for papers by Yasuo Tokita Breakdown of academic impact, for papers by E Sencer Breakdown of academic impact, for papers by Maciej Hilczer
Rankless by CCL
2026